News | August 12, 2021
Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22
Income declines marginally
Income declines marginally
The company has strong product launches both in India and overseas
The sales of vaccines have registered a growth of 41% in Q1 FY22, and the sale of health products have registered a growth of 94% in Q1 FY22.
The company has tied up with OrbiMed as a financial partner for global reach
KIMS Hospitals' brand, has an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
Board declares interim dividend of Rs 2 per equity share
Board approves fundraise of Rs 1500 crore
The company expects revenue growth of 10-15 per cent in the US
Subscribe To Our Newsletter & Stay Updated
